- Home
- RLAY vs NSSC Comparison
RLAY vs NSSC Comparison
Compare RLAY & NSSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- NSSC
- Stock Information
- Founded
- RLAY 2015
- NSSC 1969
- Country
- RLAY United States
- NSSC United States
- Employees
- RLAY N/A
- NSSC N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- NSSC Telecommunications Equipment
- Sector
- RLAY Health Care
- NSSC Telecommunications
- Exchange
- RLAY Nasdaq
- NSSC Nasdaq
- Market Cap
- RLAY 811.8M
- NSSC 967.9M
- IPO Year
- RLAY 2020
- NSSC N/A
- Fundamental
- Price
- RLAY $3.92
- NSSC $24.76
- Analyst Decision
- RLAY Strong Buy
- NSSC Strong Buy
- Analyst Count
- RLAY 10
- NSSC 5
- Target Price
- RLAY $20.11
- NSSC $40.20
- AVG Volume (30 Days)
- RLAY 1.4M
- NSSC 847.1K
- Earning Date
- RLAY 02-28-2025
- NSSC 02-03-2025
- Dividend Yield
- RLAY N/A
- NSSC 2.01%
- EPS Growth
- RLAY N/A
- NSSC 12.99
- EPS
- RLAY N/A
- NSSC 1.31
- Revenue
- RLAY $10,006,000.00
- NSSC $186,533,000.00
- Revenue This Year
- RLAY N/A
- NSSC $1.28
- Revenue Next Year
- RLAY N/A
- NSSC $11.37
- P/E Ratio
- RLAY N/A
- NSSC $18.97
- Revenue Growth
- RLAY N/A
- NSSC 5.14
- 52 Week Low
- RLAY $3.50
- NSSC $24.48
- 52 Week High
- RLAY $10.89
- NSSC $58.09
- Technical
- Relative Strength Index (RSI)
- RLAY 41.60
- NSSC 28.09
- Support Level
- RLAY $3.85
- NSSC $25.00
- Resistance Level
- RLAY $4.19
- NSSC $25.92
- Average True Range (ATR)
- RLAY 0.28
- NSSC 1.24
- MACD
- RLAY -0.02
- NSSC -0.10
- Stochastic Oscillator
- RLAY 24.80
- NSSC 5.07
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.